|
C4ORF14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.324300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.10659999999785E-05 |
| Normal-vs-Stage2 |
4.081400E-01 |
| Normal-vs-Stage3 |
5.190800E-01 |
| Normal-vs-Stage4 |
9.939800E-01 |
| Stage1-vs-Stage2 |
8.698100E-02 |
| Stage1-vs-Stage3 |
4.387699999997E-05 |
| Stage1-vs-Stage4 |
2.842400E-03 |
| Stage2-vs-Stage3 |
2.318400E-01 |
| Stage2-vs-Stage4 |
4.803200E-01 |
| Stage3-vs-Stage4 |
6.223000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.382000E-02 |
| Normal-vs-AfricanAmerican |
6.156600E-01 |
| Normal-vs-Asian |
3.742600E-01 |
| Caucasian-vs-AfricanAmerican |
4.502400E-01 |
| Caucasian-vs-Asian |
5.773800E-01 |
| AfricanAmerican-vs-Asian |
4.227200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.180500E-03 |
| Normal-vs-Female |
4.449600E-01 |
| Male-vs-Female |
5.721700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.245000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.204000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.123800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.664200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.363000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.897600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.437600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.771000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.037690E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.245710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.603760E-01 |
| Normal-vs-Grade 2 |
9.54090000000463E-05 |
| Normal-vs-Grade 3 |
1.602600E-01 |
| Normal-vs-Grade 4 |
2.637600E-02 |
| Grade 1-vs-Grade 2 |
9.892200E-01 |
| Grade 1-vs-Grade 3 |
4.119400E-01 |
| Grade 1-vs-Grade 4 |
2.149700E-02 |
| Grade 2-vs-Grade 3 |
1.764480E-02 |
| Grade 2-vs-Grade 4 |
2.9186999994657E-07 |
| Grade 3-vs-Grade 4 |
1.823850E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.54230000000744E-05 |
| Normal-vs-ccB subtype |
4.557200E-01 |
| ccA subtype-vs-ccB subtype |
4.524500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.210400E-02 |
| Normal-vs-N1 |
8.355200E-01 |
| N0-vs-N1 |
3.580800E-01 |
|
|
